Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inadvertent Pancreatic Duct Cannulation as an Independent Predictor of Post- Endoscopic Retrograde Cholangiopancreatography Pancreatitis

NCT05219123 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT05219123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05219123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inadvertent Pancreatic Duct Cannulation as an Independent Predictor of Post- Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Lead sponsor
University of Calgary
Phase
Observational
Overall status
Completed
Start date
December 20, 2021
Completion date
December 9, 2024
Enrollment
7,461 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ercp